EP1353622A4 - Procede pour ameliorer l'exposition systemique de proteines therapeutiques administrees par voie sous-cutanee - Google Patents

Procede pour ameliorer l'exposition systemique de proteines therapeutiques administrees par voie sous-cutanee

Info

Publication number: EP1353622A4
Authority: EP; European Patent Office
Prior art keywords: therapeutic proteins; systemic exposure; subcutaneously administered; administered therapeutic; improving systemic
Prior art date: 2000-11-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP01273890A

Other languages

German (de)

English (en)

Other versions

EP1353622A2 (fr

Inventor

Charles B Davis

Amarnath Sharma

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-03

Filing date

2001-11-01

Publication date

2005-06-22

2001-11-01 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2003-10-22 Publication of EP1353622A2 publication Critical patent/EP1353622A2/fr

2005-06-22 Publication of EP1353622A4 publication Critical patent/EP1353622A4/fr

Status Withdrawn legal-status Critical Current

Links

102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
230000009885 systemic effect Effects 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EP01273890A 2000-11-03 2001-11-01 Procede pour ameliorer l'exposition systemique de proteines therapeutiques administrees par voie sous-cutanee Withdrawn EP1353622A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24561800P	2000-11-03	2000-11-03
US245618P		2000-11-03
PCT/US2001/051617 WO2002083063A2 (fr)	2000-11-03	2001-11-01	Procede pour ameliorer l'exposition systemique de proteines therapeutiques administrees par voie sous-cutanee

Publications (2)

Publication Number	Publication Date
EP1353622A2 EP1353622A2 (fr)	2003-10-22
EP1353622A4 true EP1353622A4 (fr)	2005-06-22

Family

ID=22927410

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP01273890A Withdrawn EP1353622A4 (fr)	2000-11-03	2001-11-01	Procede pour ameliorer l'exposition systemique de proteines therapeutiques administrees par voie sous-cutanee

Country Status (4)

Country	Link
EP (1)	EP1353622A4 (fr)
JP (1)	JP2004532843A (fr)
AU (1)	AU2001297793A1 (fr)
WO (1)	WO2002083063A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2059253A4 (fr) *	2006-09-14	2011-09-14	Univ Pennsylvania	Modulation de lymphocytes t régulateurs par l'il-18 humaine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1013763A1 (fr) *	1997-08-07	2000-06-28	Toray Industries, Inc.	INTERLEUKINE 18 CANINE, INTERLEUKINE-1 $g(b)-CONVERTASE CANINE, SEQUENCES D'ADN CODANT CETTE ENZYME, PROCEDE DE PRODUCTION DE L'INTERLEUKINE 18, ET REMEDES CONTRE LES MALADIES IMMUNOLOGIQUES CHEZ LE CHIEN

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4847325A (en) *	1988-01-20	1989-07-11	Cetus Corporation	Conjugation of polymer to colony stimulating factor-1
US5993527A (en) *	1994-11-17	1999-11-30	Canon Kabushiki Kaisha	Ink-jet color recording process and ink set therefor

2001
- 2001-11-01 WO PCT/US2001/051617 patent/WO2002083063A2/fr not_active Ceased
- 2001-11-01 JP JP2002580868A patent/JP2004532843A/ja active Pending
- 2001-11-01 EP EP01273890A patent/EP1353622A4/fr not_active Withdrawn
- 2001-11-01 AU AU2001297793A patent/AU2001297793A1/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1013763A1 (fr) *	1997-08-07	2000-06-28	Toray Industries, Inc.	INTERLEUKINE 18 CANINE, INTERLEUKINE-1 $g(b)-CONVERTASE CANINE, SEQUENCES D'ADN CODANT CETTE ENZYME, PROCEDE DE PRODUCTION DE L'INTERLEUKINE 18, ET REMEDES CONTRE LES MALADIES IMMUNOLOGIQUES CHEZ LE CHIEN

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HERZYK, D. J. [REPRINT AUTHOR] ET AL: "Activity of human interleukin - 18 in cynomolgus monkey.", FASEB JOURNAL, (APRIL 20, 2000) VOL. 14, NO. 6, PP. A1181. PRINT. MEETING INFO.: JOINT ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS AND THE CLINICAL IMMUNOLOGY SOCIETY. SEATTLE, WASHINGTON, USA. MAY 12-16, 2000. CODEN: FAJOEC. ISSN: 08, April 2000 (2000-04-01), XP008046234 *
See also references of WO02083063A3 *

Also Published As

Publication number	Publication date
WO2002083063A3 (fr)	2003-08-28
JP2004532843A (ja)	2004-10-28
AU2001297793A1 (en)	2002-10-28
EP1353622A2 (fr)	2003-10-22
WO2002083063A2 (fr)	2002-10-24

Similar Documents

Publication	Publication Date	Title
PL335974A1 (en)	2000-06-05	Method of orally administering proteins
HUP0301164A3 (en)	2005-11-28	Method of administering bisphosphonates
AU1227302A (en)	2002-03-26	System and method for optimizing drug therapy for the treatment of diseases
EP1165048A4 (fr)	2007-12-05	Compositions et procedes d'administration amelioree d'agents therapeutiques hydrophobes ionisables
PL363322A1 (en)	2004-11-15	Combination therapy using anti-egfr antibodies and anti-hormonal agents
IL158831A0 (en)	2004-05-12	METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
EP1404343A4 (fr)	2006-08-02	Combinaisons therapeutiques pour le traitement des carences hormonales
IL157161A0 (en)	2004-02-08	Methods for treating disease states comprising administration of low levels of antibodies
IL141553A0 (en)	2002-03-10	Drug preparations for treating sexual dysfunction
IL213240A0 (en)	2011-07-31	Method of treatment using lighnd-immunogen conjugates
HUP0101017A3 (en)	2003-11-28	Compositions and methods for systemic delivery of oral vaccines and therapeutic agents
AU2002239491A1 (en)	2002-05-27	Methods for the treatment of cancer and other diseases and methods of developing the same
HUP0302050A3 (en)	2012-11-28	Pharmaceutical form of administration for peptides, method for its production and use
NO20026212D0 (no)	2002-12-23	Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
AU2002336585A1 (en)	2003-04-01	Methods and apparatus for improved administration of analgesics
HUP0001263A3 (en)	2005-11-28	Methods of therapeutic administration of anti-cd4ol compounds
AU5937901A (en)	2001-11-12	Combination therapy of respiratory diseases using antibodies
EP1353622A4 (fr)	2005-06-22	Procede pour ameliorer l'exposition systemique de proteines therapeutiques administrees par voie sous-cutanee
SI1296689T1 (sl)	2006-08-31	Nacin dajanja pacientu bisfosfonatov
IL155819A0 (en)	2003-12-23	Methods of treatment comprising administration of substance p
IL156655A0 (en)	2004-01-04	Hormone replacement therapy method and its administration form
AU2002360696A1 (en)	2003-07-30	Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
AU2002351798A1 (en)	2003-05-12	Methods and dosage forms for improving the bioavailability of therapeutic agents
AU2002328905A1 (en)	2003-03-03	A method for determining the therapeutic effectiveness of a substance using a microphysiometer and use of the method
AU6884801A (en)	2002-01-14	Therapeutic compounds and methods

Legal Events

Date	Code	Title	Description
2003-09-05	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-10-22	17P	Request for examination filed	Effective date: 20030506
2003-10-22	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2003-10-22	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2005-06-22	A4	Supplementary search report drawn up and despatched	Effective date: 20050511
2005-06-22	RIC1	Information provided on ipc code assigned before grant	Ipc: 7A 61P 35/00 B Ipc: 7A 61P 33/00 B Ipc: 7A 61P 31/00 B Ipc: 7A 61K 6/00 A
2008-11-14	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2008-12-17	18D	Application deemed to be withdrawn	Effective date: 20080603